Company Filing History:
Years Active: 2014-2023
Title: Christopher Peter McCready: Innovator in Bioreactor Technology
Introduction
Christopher Peter McCready is a notable inventor based in London, Canada. He has made significant contributions to the field of bioreactor technology, particularly in the area of cell metabolism state observation. With a total of five patents to his name, McCready's work focuses on enhancing the understanding and prediction of biomaterial production in biological systems.
Latest Patents
One of McCready's latest patents is a computer-implemented method, computer program product, and hybrid system for cell metabolism state observation. This innovative technique provides methods for predicting the amount of biomaterial produced or consumed by a biological system in a bioreactor. The process involves measuring process conditions and metabolite concentrations over time. It also includes determining metabolic rates, such as specific consumption and production rates of metabolites. The data is then utilized in a hybrid system model designed to predict biomaterial production. This model incorporates a kinetic growth model to estimate cell growth and a metabolic condition model that classifies the biological system into a metabolic state. Ultimately, the hybrid system model predicts the amount of biomaterial based on the collected data.
Career Highlights
Throughout his career, McCready has worked with prominent companies in the industry, including MKS Instruments, Inc. and Sartorius Stedim Data Analytics AB. His experience in these organizations has allowed him to develop and refine his innovative approaches to bioreactor technology.
Collaborations
Some of McCready's notable coworkers include Nicholas Trunfio and Svante Bjarne Wold. Their collaborative efforts have contributed to advancements in the field and have fostered a productive environment for innovation.
Conclusion
Christopher Peter McCready is a distinguished inventor whose work in bioreactor technology has paved the way for improved understanding and prediction of biomaterial production. His contributions through patents and collaborations highlight his commitment to innovation in the field.